Target
DNA/histone H1 complex
Description
Anti-DNA/histone H1 complex Antibody, Highly Galactosylated (BioBet-GA-188ZP) is a chimeric IgG1, κ antibody against DNA/histone H1 complex which contains with a high level of galactosylation.
Antibody Indication
Glioblastoma multiforme (GBM), Cancers, brain, malignant glioma, Solid tumors
Classification
Therapeutic antibody; biobetter
Cooperation Seeking
Creative Biolabs is interested in collaborating with potential partners (include but not limit to major pharma or biotech firms) to further co-develop ADCC-enhanced DNA/histone H1 complex antibody. For commercial partners interested in our ADCC-enhanced therapeutic antibodies, Creative Biolabs welcomes collaboration. Here are two ways for your choice, and please contact us for more details.
1) Collaborate with us and co-develop the programs from discovery phase to IND enabling. Costs will be shared.
2) Become a licensed candidate of our programs.
Looking forward to cooperating with you in the near future.
Biologic Classification
Protein Based Therapies
Monoclonal antibody (mAb)
Antibody Clone
BioBet-GA-188ZP
Description
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to DNA/histone (H1) complex. Derlotuximab is a human monoclonal antibody that can be potentially used in the treatment of Glioblastoma multiforme (GBM), Cancers, brain, malignant glioma, Solid tumors.
Antibody Indication
Glioblastoma multiforme (GBM), Cancers, brain, malignant glioma, Solid tumors
